from Reuters: Business News https://ift.tt/2qAWekN
Monday, April 16, 2018
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
LONDON (Reuters) - Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.
from Reuters: Business News https://ift.tt/2qAWekN
from Reuters: Business News https://ift.tt/2qAWekN
Related Posts:
Bayer hires law firm to probe Monsanto data collection- France to push ahead with 5G launch in 2020 despite Huawei woes
- China rare earth firms' stocks soar on trade war speculation
- J.C. Penney posts steeper-than-expected drop in same-store sales
- Huawei accuses U.S. of bullying, says working with Google to counter ban
0 comments:
Post a Comment